- Udyam number
- UDYAM-HR-18-0022804

About Medcell Pharma Private Limited
Data last updated:
Medcell Pharma Private Limited is a private limited company based in Gurugram, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 September 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230HR2022PTC106564. Its GSTIN is 06AAQCM1857L1ZW (Haryana).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Gunjan Bhatia and Aditya Bhatia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 711 Sushant Lok – 1 Sukhrali Chakkarpur, Gurugram, Haryana, India – 122009.
As per the financials filed for FY 2025, the company reported a revenue of ₹63.46 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹5.66 Cr (net margin -8.9%) and EBITDA of -₹4.87 Cr (EBITDA margin -7.7%).
The company has about 208 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Medcell Pharma. As per MCA filings, the company has open charges of ₹32 Cr on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it; 3 cases are pending.
Medcell Pharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-HR-18-0022804). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medcellpharma.com.
Company details
Recognitions & Rankings of Medcell Pharma
Contact details
Medcell Pharma Private Limited's registered office is in Gurugram, Haryana. Its website is medcellpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressB – 711 Sushant Lok – 1 Sukhrali Chakkarpur, Gurugram, Haryana, India – 122009
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medcell Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Medcell Pharma operates one associated brand: Medcell Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical and nutraceutical products for health improvement and partnerships. | medcellpharma.com |
Business activity
The main business activity of Medcell Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Medcell Pharma Private Limited, buy the company report.
Financials of Medcell Pharma Private Limited
FY 2025 filings availableMedcell Pharma Private Limited reported revenue of ₹63.46 Cr (up 621% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 621% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹63.46 Cr | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹4.87 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹5.66 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -7.7% | ||
| Net Profit Margin | -8.9% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Medcell Pharma Private Limited, buy the company report.
Board of directors of Medcell Pharma Private Limited
Medcell Pharma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gunjan Bhatia | Director | 13 Sep 2022 | 4 Years 1 Months | Current |
| Aditya Bhatia | Director | 13 Sep 2022 | 4 Years 1 Months | Current |
| Anita Bhatia Also directs: Ruxall Vita Private Limited, Zypher Lifesciences Private Limited | Director | 01 Sep 2023 | 3 Years 1 Months | Current |
Peer comparison
Medcell Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| SKJ Healthcare Private Limited | ₹63.89 Cr (FY 2024) | 123.0% | Ahmedabad, Gujarat, India | |||
| B M V Fragrances Private Limited | ₹63.81 Cr (FY 2025) | 1.0% | New Delhi, Delhi, India | |||
| Steris Healthcare Private Limited | ₹63.79 Cr (FY 2024) | 41.0% | Jaipur, Rajasthan, India | |||
| Aero Agro Chemical Industries Ltd. | ₹63.74 Cr (FY 2024) | -29.0% | Kolkata, West Bengal, India | |||
| Kilitch Healthcare India Limited | ₹63.63 Cr (FY 2024) | 7.0% | Mumbai, Maharashtra, India | |||
| Medcell Pharma Private Limitedthis company | ₹63.46 Cr (FY 2025) | -₹5.66 Cr | -8.9% | 621.0% | 208 | Gurugram, Haryana, India |
| Sance Laboratories Private Limited | ₹63.45 Cr (FY 2025) | 14.0% | Kottayam, Kerala, India | |||
| Zenith Dyeintermediates Limited | ₹63.4 Cr (FY 2025) | 21.0% | Mumbai, Maharashtra, India | |||
| Adley Lab Limited | ₹63.38 Cr (FY 2025) | 19.0% | Derabassi, Punjab, India | |||
| New Alliance Fine Chem Private Limited | ₹63.38 Cr (FY 2025) | 15.0% | Mumbai, Maharashtra, India | |||
| Panchwati Prayogshala Private Limited | ₹63.37 Cr (FY 2024) | -32.0% | Roorkee, Uttarakhand, India |
To see the full peer comparison of Medcell Pharma Private Limited, buy the company report.
Shareholding
The shareholding of Medcell Pharma Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Medcell Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 May 2025 | 101107315 | Hdfc Bank Limited | ₹10 Cr | Open | |
| 28 Feb 2024 | 100876815 | Hdfc Bank Limited | ₹22 Cr | Open |
To see the full charge records of Medcell Pharma Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Medcell Pharma Private Limited has 3 court cases on record: 2 filed by Medcell Pharma, 1 filed against it. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 1 | 3 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chamba, Himachal Pradesh | Court case (Drugs And Cosmetics Act) | Filed against the company | Pending |
| District court, Panipat, Haryana | Cheque dishonour complaint | Filed by the company against Apex Pharmaceuticals Distributors | Pending |
| District court, BAGALKOT, Karnataka | Criminal miscellaneous application | Filed by the company against State at the Instance of Asst. Drugs Controller | Pending |
To see the full case history of Medcell Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medcell Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Medcell Pharma Private Limited has a workforce of 208 employees on its EPFO records as of Sep 25, 2025, across 1 active EPFO establishment.
GST
Medcell Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAQCM1857L1ZW | Haryana | Active | 10 Dec 2022 |
To see the full GST registrations and return filing status of Medcell Pharma Private Limited, buy the company report.
Recent activity
Medcell Pharma Private Limited has 3 board changes on record since 2022: 3 appointments. The latest: Anita Bhatia was appointed as Director on 01 Sep 2023.
Frequently asked questions
Medcell Pharma is an active private limited company based in Gurugram, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 September 2022 (4+ years old) and is registered under CIN U24230HR2022PTC106564.
Medcell Pharma has 3 current directors:
- Gunjan Bhatia - Director
- Aditya Bhatia - Director
- Anita Bhatia - Director
The latest financial statements of Medcell Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Medcell Pharma is 06AAQCM1857L1ZW, registered in Haryana.
The CIN (Corporate Identification Number) of Medcell Pharma is U24230HR2022PTC106564. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medcell Pharma has 3 court cases on record: 2 filed by the company and 1 filed against it. 3 are pending.
Medcell Pharma was incorporated on 13 September 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Medcell Pharma by revenue are SKJ Healthcare Private Limited, B M V Fragrances Private Limited, Steris Healthcare Private Limited, Aero Agro Chemical Industries Ltd, Kilitch Healthcare India Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Anita Bhatia was appointed as Director on 01 Sep 2023. Aditya Bhatia was appointed as Director on 13 Sep 2022. Gunjan Bhatia was appointed as Director on 13 Sep 2022.
Yes, Medcell Pharma is registered as an MSME under Udyam registration (number: UDYAM-HR-18-0022804).
Medcell Pharma can be reached through the website medcellpharma.com. Its registered office is in Gurugram, Haryana, India.